Please provide your email address to receive an email when new articles are posted on . Historically, patient-reported outcome measures were primarily used for research. Today, surgeons use ...
Patient-reported outcome measures improve survival risk and quality of life for cancer patients, according to a study published Aug. 13 in JAMA Network Open. PROMs are self-reported statements from ...
Analysis of the phase 3 explorer7 (NCT04083781) study indicates a preference for concizumab prophylaxis over no prophylaxis in patients with hemophilia A or B with inhibitors. Among individuals with ...
Adjuvant therapy with Imfinzi (durvalumab) and Imjudo (tremelimumab-actl) in patients with resected renal cell carcinoma was ...
MedPage Today on MSN
Quality-of-Life Outcomes Underreported in GU Cancer Trials
Of the phase III trials that planned to report QoL outcomes, nearly 40% never did ...
There is a lack of systematic solutions to manage supportive care issues in racial/ethnic minorities (REM) receiving treatment for cancer. We developed and implemented an electronic patient-reported ...
Results presented here showed negative pressure wound therapy is a safe adjunct for soft tissue sarcoma treated with ...
SAN DIEGO, June 2, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced new data from the Phase 4 KINECT-PROTM open-label study demonstrating robust and sustained ...
The Adapt Oculus trial is unique in that it includes a patient population often overlooked in clinical trials, patients ...
Patient-reported outcomes (PROs) have rapidly become integral to cancer care, offering invaluable insights by capturing the patient’s perspective on symptoms, quality of life, and treatment-related ...
Abrocitinib shows sustained improvement in atopic dermatitis symptoms over two years with an acceptable safety profile.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results